Expansion of a unique CD57 +NKG2C hi natural killer cell subset during acute human cytomegalovirus infection

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 36, 2011, Pages 14725-14732

  Lopez Vergès, Sandra ^a   Milush, Jeffrey M ^a   Schwartz, Brian S ^b   Pando, Marcelo J ^c   Jarjoura, Jessica ^a   York, Vanessa A ^a   Houchins, Jeffrey P ^d   Miller, Steve ^a   Kang, Sang Mo ^b   Norris, Phillip J ^a,e   Nixon, Douglas F ^a   Lanier, Lewis L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d R and D Systems Inc   (United States)

^e BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

Author keywords

Innate immunity; Lymphocyte

Indexed keywords

CD57 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1;

ARTICLE; CELL EXPANSION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CELL; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACUTE DISEASE; ANTIGENS, CD56; ANTIGENS, CD57; BIOLOGICAL MARKERS; CELL DEGRANULATION; CELL PROLIFERATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION REGULATION; GPI-LINKED PROTEINS; HLA-B ANTIGENS; HUMANS; IMMUNOLOGIC MEMORY; KILLER CELLS, NATURAL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; ORGAN TRANSPLANTATION; RECEPTORS, IGG; RECEPTORS, KIR3DL1; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

HUMAN HERPESVIRUS 5;

EID: 80052602721     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1110900108     Document Type: Article

References (65)

1. Caligiuri MA (2008) Human natural killer cells. Blood 112:461-469.
2. Lanier LL (2008) Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 8:259-268.
3. Biron CA, Byron KS, Sullivan JL (1989) Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320:1731-1735. (Pubitemid 19163129)
4. Orange JS (2002) Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect 4:1545-1558.
5. Etzioni A, et al. (2005) Fatal varicella associated with selective natural killer cell deficiency. J Pediatr 146:423-425. (Pubitemid 40341757)
6. Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH (1986) The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 136:4480-4486. (Pubitemid 16090665)
7. Lanier LL (2008) Up on the tightrope: Natural killer cell activation and inhibition. Nat Immunol 9:495-502.
8. Pass R (2001) Cytomegalovirus. Fields Virology, eds Knipe D, Howley PM, Griffin DE, Lamb RA (Lippincott Williams and Wilkins, Philadelphia), pp 2675-2705.
9. Ho M (1990) Epidemiology of cytomegalovirus infections. Rev Infect Dis 12(suppl 7): S701-S710.
10. López-Botet M, Angulo A, Gumá M (2004) Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. Tissue Antigens 63:195-203.
11. Bennett NJ, et al. (2010) Intracellular sequestration of the NKG2D ligand ULBP3 by human cytomegalovirus. J Immunol 185:1093-1102.
12. Magri G, et al. (2011) NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 117:848-856.
13. Welte SA, et al. (2003) Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur J Immunol 33:194-203. (Pubitemid 36157657)
14. Cosman D, et al. (2001) ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14:123-133. (Pubitemid 32206515)
15. Sutherland CL, et al. (2002) UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. J Immunol 168:671-679. (Pubitemid 34049567)
16. Beck S, Barrell BG (1988) Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 331:269-272. (Pubitemid 18040595)
17. Prod'homme V, et al. (2007) The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells. J Immunol 178:4473-4481. (Pubitemid 46492399)
18. Leong CC, et al. (1998) Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: The role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med 187:1681-1687. (Pubitemid 28235109)
19. Lanier LL, Corliss B, Wu J, Phillips JH (1998) Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 8:693-701. (Pubitemid 28294516)
20. Braud VM, et al. (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391:795-799. (Pubitemid 28099678)
21. Valés-Gómez M, Reyburn HT, Erskine RA, López-Botet M, Strominger JL (1999) Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J 18:4250-4260. (Pubitemid 29364127)
22. Gumá M, et al. (2004) Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104:3664-3671. (Pubitemid 39564443)
23. Gumá M, et al. (2006) Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J Infect Dis 194:38-41.
24. Monsiváis-Urenda A, et al. (2010) Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children. Eur J Immunol 40:1418-1427.
25. Gumá M, et al. (2006) Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 107:3624-3631.
26. Kuijpers TW, et al. (2008) Human NK cells can control CMV infection in the absence of T cells. Blood 112:914-915.
27. O'Leary JG, Goodarzi M, Drayton DL, Von Andrian UH (2006) T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 7: 507-516.
28. Sun JC, Beilke JN, Lanier LL (2009) Adaptive immune features of natural killer cells. Nature 457:557-561.
29. Paust S, et al. (2010) Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol 11:1127-1135.
30. Béziat V, Descours B, Parizot C, Debré P, Vieillard V (2010) NK cell terminal differentiation: Correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS ONE 5:e11966.
31. Björkström NK, et al. (2010) Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 116:3853-3864.
32. Lopez-Vergès S, et al. (2010) CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood 116:3865-3874.
33. Sun JC, Lopez-Verges S, Kim CC, DeRisi JL, Lanier LL (2011) NK cells and immune "memory". J Immunol 186:1891-1897.
34. Fishman JA (2007) Infection in solid-organ transplant recipients. N Engl J Med 357: 2601-2614.
35. Fishman JA, et al. (2007) Cytomegalovirus in transplantation - Challenging the status quo. Clin Transplant 21:149-158.
36. Orr MT, Murphy WJ, Lanier LL (2010) 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat Immunol 11:321-327.
37. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P (1995) The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 181:1133-1144.
38. Lanier LL, et al. (1995) The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. J Immunol 154:3320-3327.
39. Colonna M, Samaridis J (1995) Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268: 405-408.
40. Valés-Gómez M, Reyburn HT, Erskine RA, Strominger J (1998) Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. Proc Natl Acad Sci USA 95:14326-14331. (Pubitemid 28549366)
41. Villard J (2006) Immunity after organ transplantation. Swiss Med Wkly 136:71-77.
42. Chiossone L, et al. (2007) Molecular analysis of the methylprednisolone- mediated inhibition of NK-cell function: Evidence for different susceptibility of IL-2- versus IL-15-activated NK cells. Blood 109:3767-3775. (Pubitemid 46641727)
43. Wai LE, Fujiki M, Takeda S, Martinez OM, Krams SM (2008) Rapamycin, but not cyclosporine or FK506, alters natural killer cell function. Transplantation 85:145-149.
44. Wang H, et al. (2007) The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations. Blood 110:1530-1539. (Pubitemid 47443969)
45. Kaiser BK, et al. (2005) Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics. J Immunol 174:2878-2884. (Pubitemid 40279705)
46. Pietra G, Romagnani C, Moretta L, Mingari MC (2009) HLA-E and HLA-E-bound peptides: Recognition by subsets of NK and T cells. Curr Pharm Des 15:3336-3344.
47. Björkström NK, et al. (2011) Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med 208:13-21.
48. Tomasec P, et al. (2000) Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287:1031.
49. Llano M, Gumá M, Ortega M, Angulo A, López-Botet M (2003) Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: Impact on target susceptibility to NK cell subsets. Eur J Immunol 33: 2744-2754. (Pubitemid 37337140)
50. Ulbrecht M, et al. (2003) HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis. Hum Immunol 64: 231-237. (Pubitemid 36197351)
51. Cerboni C, et al. (2001) Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity. Eur J Immunol 31:2926-2935. (Pubitemid 32994544)
52. Wang EC, et al. (2002) UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc Natl Acad Sci USA 99:7570-7575. (Pubitemid 34568732)
53. Hadaya K, et al. (2008) Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation. Am J Transplant 8:2674-2683.
54. Dokun AO, et al. (2001) Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2:951-956. (Pubitemid 32976168)
55. Brenchley JM, et al. (2003) Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101:2711-2720. (Pubitemid 36857634)
56. Focosi D, Bestagno M, Burrone O, Petrini M (2010) CD57+ T lymphocytes and functional immune deficiency. J Leukoc Biol 87:107-116.
57. Le Priol Y, et al. (2006) High cytotoxic and specific migratory potencies of senescent CD8+ CD57+ cells in HIV-infected and uninfected individuals. J Immunol 177: 5145-5154. (Pubitemid 44527586)
58. Chong LK, et al. (2008) Proliferation and interleukin 5 production by CD8hi CD57+ T cells. Eur J Immunol 38:995-1000.
59. Lutz CT, et al. (2011) Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults. J Immunol 186:4590-4598.
60. Pitcher CJ, et al. (2002) Development and homeostasis of T cell memory in rhesus macaque. J Immunol 168:29-43. (Pubitemid 34014099)
61. Sáez-Borderías A, et al. (2009) IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function. J Immunol 182: 829-836.
62. Saverino D, et al. (2004) Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus- infected cells. J Immunol 172:5629-5637. (Pubitemid 38542066)
63. Sun JC, Lanier LL (2009) Natural killer cells remember: An evolutionary bridge between innate and adaptive immunity? Eur J Immunol 39:2059-2064.
64. Vivier E, et al. (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331:44-49.
65. Miller S, Seet H, Khan Y, Wright C, Nadarajah R (2010) Comparison of QIAGEN automated nucleic acid extraction methods for CMV quantitative PCR testing. Am J Clin Pathol 133:558-563.